Business
Kenyan pharmaceutical company gains entry to global market
Saturday, October 29, 2011
A Kenyan pharmaceutical company has won World Health Organization (WHO) certification for one of its drugs, opening the door to lucrative tenders floated by the Global Fund.
Universal Corporation’s Lamozid, an anti-retroviral drug, was pre-qualified last Friday and included in a list of about 255 drugs approved for the fund which spends Sh2 trillion (US$20 billion) annually on combating malaria, Aids, tuberculosis, and more recently, reproductive health.
Continue Reading